Patent classifications
A23C21/08
Method for Producing Extruded Puffed Protein
Disclosed is a method for extruding protein, such as whey protein, for example, in a puffed form that can readily be ground, milled, or otherwise reduced in size to produce protein powder that can be used to reduce hardening in protein bars. The method uses acidification of the protein to modify its behavior during the extrusion process and produce extruded products (e.g., crisps) with improved properties.
Production of protein-polysaccharide conjugates
The present invention provides novel compositions and methods for producing protein-polysaccharide conjugates in aqueous solutions. Also provided are methods for limiting the Maillard reaction to the very initial stage, the formation of the Schiff base. Provided are methods to obtain a simple product of Schiff base with white color, and compositions obtained using the methods of the present invention.
Production of protein-polysaccharide conjugates
The present invention provides novel compositions and methods for producing protein-polysaccharide conjugates in aqueous solutions. Also provided are methods for limiting the Maillard reaction to the very initial stage, the formation of the Schiff base. Provided are methods to obtain a simple product of Schiff base with white color, and compositions obtained using the methods of the present invention.
Food products comprising milk proteins and non-animal proteins, and methods of producing the same
Provided are food products comprising milk proteins and non-animal proteins, and methods of manufacturing the same.
Food products comprising milk proteins and non-animal proteins, and methods of producing the same
Provided are food products comprising milk proteins and non-animal proteins, and methods of manufacturing the same.
NUTRITIONAL COMPOSITIONS AND METHODS RELATED THERETO
The present invention relates to methods for preparing liquid nutritional compositions, including liquid nutritional compositions comprising one or more proteins such as milk proteins, the liquid nutritional compositions themselves, and to methods for using such liquid nutritional compositions.
Solid fermented milk composition
Fermented milk bases and methods of making fermented milk bases are disclosed. Such fermented milk bases are solid and contain little or no non-dairy stabilizers and non-dairy thickeners. Also disclosed are packaged food products including the disclosed fermented milk bases.
Solid fermented milk composition
Fermented milk bases and methods of making fermented milk bases are disclosed. Such fermented milk bases are solid and contain little or no non-dairy stabilizers and non-dairy thickeners. Also disclosed are packaged food products including the disclosed fermented milk bases.
CHEESECAKE AND METHOD OF PRODUCING SAME
The invention relates to a baked cheesecake comprising a crust and a filling wherein the filling comprises 2-7 wt. % , based on the dry weight of the filling, of whey protein preferably derived from a whey protein source comprising at least 34% whey protein by weight. The invention is based on the finding that the use of certain whey proteins are able to reduce or even prevent crack formation in the filling of baked cheesecake. The invention is further related to a method of preparing a baked cheesecake, wherein use is made of specific whey proteins. Further, the invention pertains to a powdered ingredient composition suitable for preparing a cheesecake filling that comprises, based on total weight of the composition, 4-30 wt. % of a whey protein source preferably comprising at least 34% whey protein by weight, 25-45 wt. % fat and 25-50 wt. % carbohydrates.
FORMULATIONS INCLUDING DIHYDROHONOKIOL
Disclosed herein are compositions for treating anxiety and related disorders. In some embodiments, the compositions comprise dihydrohonokiol-B (“DHH-B”) and at least one pharmaceutically acceptable carrier, wherein the DHH-B is present in an amount ranging from between about 0.5% to about 25% by total weight of the composition. In other embodiments, the compositions comprise dihydrohonokiol-B (“DHH-B”) and at least one pharmaceutically acceptable carrier, wherein the DHH-B is present in an amount ranging from between about 0.000001% to about 5% by total weight of the composition.